Get the latest Science News and Discoveries

Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs

Haitham Amal, co-founder of Point6 Bio, develops small-molecule drugs that show promise across autism, Alzheimers and gliobastoma.

None

Get the Android app